What is LOPJLB’s current signal on BCYC?

LOPJLB’s latest quantitative signal on Bicycle Therapeutics plc (BCYC) is SELL in a RECOVERY regime. Signals are updated daily.

What market regime is BCYC in?

Bicycle Therapeutics plc (BCYC) is currently classified in the RECOVERY HMM market regime on LOPJLB.

Where is Bicycle Therapeutics plc based / listed?

Bicycle Therapeutics plc is based in GB, listed on NASDAQ.

Bicycle Therapeutics plc (BCYC)

COMPARE

Healthcare · Biotechnology · NASDAQ · GB

$3.81+2.14%Close

SELLRECOVERY · day 4

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-15

Market cap: $264M
Beta: 1.68
P/E (TTM): -1.39

Short % float: 5.42%
Days to cover: 6.7
SI change: +1.5%

1W: +7.02%
1M: -4.99%

vs SPY 1W: +5.46%
vs SPY 1M: -6.75%

Industry peers

FMP comparable companies · ranked by market cap

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

Bicycle Therapeutics plc, founded in 2009 and based in Cambridge, UK, is a clinical-stage biopharmaceutical company. Its core mission is to create innovative therapeutic classes for diseases currently lacking effective treatments. The company's leading investigational product,…

Employees: 288
Headquarters: GB
Founded: 2019
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares out: 69.4M
Float: 88.6%

bicycletherapeutics.com ↗

Key executives

Kevin Lee — Chief Executive Officer & Executive Director

Michael Skynner — Chief Scientific Officer

Alistair Milnes — Chief Corporate Development Officer

SEC filings

EDGAR · CIK 17616120 · BCYC

Analyst consensus

Buy

Bullish1781.0%

Neutral419.0%

Bearish00.0%

L $12.00Avg $12.00H $12.00

Target$12.00+214.96%

Last$3.81

Key stats

Industry peers

Prediction markets

Company news